Results 11 to 20 of about 49,590 (306)
Effects of a Personalized Nurse-Led Educational Program for New Patients Receiving Oral Anticoagulant Therapy after Mechanical Heart Valve Prosthesis Implantation on Adherence to Treatment [PDF]
Background: Life-long anticoagulant therapy is mandatory for patients who undergo heart valve replacement with implantation of a mechanical prosthesis.
Rokeia Eltheni+3 more
doaj +10 more sources
Transcatheter aortic valve‐in‐valve implantation of a corevalve in a degenerated stenotic sapien heart valve prosthesis [PDF]
Treatment options for re‐stenotic aortic valve prosthesis implanted by transcatheter technique have not been evaluated systematically. We describe the case of a 75‐year‐old dialysis patient who was treated by transcatheter aortic valve implantation 3.5 years ago and now presented with severe stenosis of the percutaneous heart valve.
Rainer Hoffmann+2 more
semanticscholar +5 more sources
This study was done to assess the results of percutaneous heart valve (PHV) implantation in non-surgical patients with end-stage calcific aortic stenosis.Replacement of PHV has been shown to be feasible in animals and humans. We developed a PHV composed of three pericardial leaflets inserted within a balloon-expandable stainless steel stent.
Fabrice Bauer+10 more
semanticscholar +5 more sources
Advances in the diagnosis and management of congenital heart disease (CHD) have resulted in an increased number of patients living into adulthood. Despite increased survival, these patients often require surgery at a young age and are susceptible to developing complications related to the degeneration of surgical prostheses and valves.
Clare Rayner+3 more
+6 more sources
We evaluated early outcomes of transcatheter valve‐in‐valve (ViV) implantation in patients with degenerated bio‐prosthesis in tricuspid position. Total of 5 patients were included in our case series.
Mann Chandavimol+7 more
doaj +2 more sources
German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation—Outcomes of the MYLAND (MYvaL germAN stuDy) Study [PDF]
Background: The primary objective of this study was to evaluate the initial experience in Germany with the Meril Myval™ (MM) transcatheter heart valve (THV) system for the treatment of severe symptomatic aortic valve stenosis. The MM THV is a novel balloon-expandable valve with an expanded sizing matrix.
Timm Ubben+9 more
openaire +4 more sources
The pandemic changed the type of patients. The concept of “patient at the center” became concrete. The execution of simple consultancy was overcome to create effective collaboration and fruitful exchanges between specialists. The “Heart Team” model is on increasing affirmation.
Manes, Maria Teresa+6 more
openaire +4 more sources
A certain degree of prosthesis oversizing (OS) is recommended for the SAPIEN 3 to achieve device success. However, an increase in OS may increase permanent pacemaker implantation (PPI) rates. We therefore investigated the influence of OS on device failure and PPI.A total of 804 patients were treated with SAPIEN 3 at 3 centers.
Heribert Schunkert+18 more
openaire +6 more sources
Background: Prosthesis sizing in transcatheter aortic valve replacement (TAVR) uses certain prosthesis oversizing (OS) to achieve device success. However, an increase in OS may increase the need for permanent pacemaker implantations (PPI).
Albert M. Kasel+15 more
openaire +3 more sources
An examination of 39 patients with heart diseases was performed before and after operations by the method of geometrical analysis of the nonlinear chaos (fractal) variability of the cardiac rhythm on the basis of the apparatus-programmed complex "Poly-spectrum". Five-minute-long registrations of ECG were carried on.
A P, Medvedev+4 more
openaire +2 more sources